Chrna2 is a nicotinic cholinergic receptor subunit and is a clinical target for AD (Xu et al., 2021), with specific polymorphisms noted for Chinese (Ding et al., 2023) and Korean (Kim et al., 2024) populations. The gene discussed is CHRNA2; the disease is Alzheimer disease.